Encino, California
United States
35
2026-05-14
The entities that hold a legal rights for patent applications filed by inventor Hedvat Michael:
Michael Hedvat from Encino, US has applied for patents for these inventions. The list has both pending applications and granted patents:
BISPECIFIC ANTIBODIES THAT BIND PD-L1 AND CD28
#2 | 2025-12-25ANTI-CD28 X ANTI-PSMA ANTIBODIES
#3 | 2025-10-30BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES
#4 | 2025-04-17ANTI-CD20 x ANTI-CD28 COMBINATION THERAPIES
#5 | 2025-02-06ANTI-CD28 COMPOSITIONS
#6 | 2024-12-19HETERODIMERIC ANTIBODIES THAT BIND PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AND CD3
#7 | 2024-08-22HETERODIMERIC ANTIBODIES THAT BIND MSLN AND CD3
#8 | 2024-07-04ANTI-CD28 X ANTI-PSMA ANTIBODIES
#9 | 2024-02-22ANTI-CD28 X ANTI-TROP2 ANTIBODIES
#10 | 2024-01-25BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND CHECKPOINT RECEPTORS
#11 | 2023-11-30ANTIBODIES THAT BIND PD-L1, PD-L2, AND/OR CD28
#12 | 2023-10-26ANTI-CD28 X ANTI-MSLN ANTIBODIES
#13 | 2023-10-12ANTI-CD28 X ANTI-PSMA ANTIBODIES
#14 | 2023-08-24ANTI-CD28 X ANTI-PSMA ANTIBODIES
#15 | 2023-08-17ANTI-CD28 COMPOSITIONS
#16 | 2023-02-23PD-1 TARGETED IL-15/IL-15RALPHA FC FUSION PROTEINS AND USES IN COMBINATION THERAPIES THEREOF
#17 | 2023-02-09BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES
#18 | 2022-06-30Bispecific and monospecific antibodies using novel anti-PD-1 sequences
#19 | 2022-05-05BISPECIFIC ANTIBODIES THAT BIND PD-L1 AND CD28
#20 | 2022-04-21Anti-CD28 compositions
#21 | 2022-04-21Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3
#22 | 2022-04-07HETERODIMERIC ANTIBODIES THAT BIND MSLN AND CD3
#23 | 2022-03-31Anti-CD28 compositions
#24 | 2021-11-18Targeted IL-12 heterodimeric Fc-fusion proteins
#25 | 2021-08-19BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND CHECKPOINT RECEPTORS
#26 | 2021-06-10Untargeted and targeted IL-10 Fc-fusion proteins
#27 | 2021-04-01BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND CHECKPOINT RECEPTORS
#28 | 2020-05-07PD-1 targeted IL-15/IL-15RALPHA fc fusion proteins and uses in combination therapies thereof
#29 | 2019-12-26Bispecific checkpoint inhibitor antibodies
#30 | 2019-12-19Bispecific checkpoint inhibitor antibodies
#31 | 2019-09-05Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
#32 | 2019-08-29Bispecific and monospecific antibodies using novel anti-PD-1 sequences
#33 | 2018-05-10Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
#34 | 2018-05-03Bispecific checkpoint inhibitor antibodies
#35 | 2007-05-10Composition and method for the treatment of cancer and other physiologic conditins based on modulation of the ppar-gamma pathway and her-kinase axis
2184029 ⎘